Your search returned 2 results.

Results
	1.	The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study. [electronic resource] by Fiala, Ondrej Finek, Jindrich Buchler, Tomas Matejka, Vit Martin Holubec, Lubos Kulhankova, Jana Bortlicek, Zbynek Liska, Vaclav Topolcan, Ondrej Producer: 20161006 In: Targeted oncology vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab. [electronic resource] by Fiala, Ondrej Buchler, Tomas Mohelnikova-Duchonova, Beatrice Melichar, Bohuslav Matejka, Vit Martin Holubec, Lubos Kulhankova, Jana Bortlicek, Zbynek Bartouskova, Marie Liska, Vaclav Topolcan, Ondrej Sedivcova, Monika Finek, Jindrich Producer: 20170206 In: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search